Louis ED, Ottman R. How many people in the USA have essential tremor? Deriving a population estimate based on epidemiological data. Tremor Other Hyperkinet Mov (N Y). 2014;4:259.

Article  Google Scholar 

Louis ED, McCreary M. How common is essential Tremor? Update on the Worldwide Prevalence of essential tremor. Tremor Other Hyperkinet Mov (N Y). 2021;11:28.

Article  Google Scholar 

Thenganatt MA, Louis ED. Distinguishing essential tremor from Parkinson’s disease: bedside tests and laboratory evaluations. Expert Rev Neurother. 2012;12(6):687–96.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Louis ED, Faust PL. Essential tremor pathology: neurodegeneration and reorganization of neuronal connections. Nat Rev Neurol. 2020.

Louis ED, Faust PL, Vonsattel JPG, Honig LS, Rajput A, Robinson CA, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain. 2007;130(12):3297–307.

Article  PubMed  Google Scholar 

Louis ED, Martuscello RT, Gionco JT, Hartstone WG, Musacchio JB, Portenti M, et al. Histopathology of the cerebellar cortex in essential tremor and other neurodegenerative motor disorders: comparative analysis of 320 brains. Acta Neuropathol. 2023;145(3):265–83.

Article  PubMed  PubMed Central  Google Scholar 

Welton T, Cardoso F, Carr JA, Chan LL, Deuschl G, Jankovic J, et al. Essential tremor. Nat Rev Dis Primers. 2021;7(1):83.

Article  PubMed  Google Scholar 

Bruce KD, Zsombok A, Eckel RH. Lipid Processing in the brain: a Key Regulator of systemic metabolism. Front Endocrinol (Lausanne). 2017;8:60.

Article  PubMed  Google Scholar 

Calon F. Modulation des lipides du cerveau par l’alimentation: études chez des modèles animaux de maladies neurodégénératives. Cahiers De Nutr et de Diététique. 2014;49(3):120–5.

Article  Google Scholar 

Söderberg M, Edlund C, Kristensson K, Dallner G. Lipid compositions of different regions of the human brain during aging. J Neurochem. 1990;54(2):415–23.

Article  PubMed  Google Scholar 

Ouellet M, Emond V, Chen CT, Julien C, Bourasset F, Oddo S, et al. Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: an in situ cerebral perfusion study. Neurochem Int. 2009;55(7):476–82.

Article  PubMed  CAS  Google Scholar 

Hamilton LK, Dufresne M, Joppé SE, Petryszyn S, Aumont A, Calon F, et al. Aberrant lipid metabolism in the Forebrain Niche suppresses adult neural stem cell proliferation in an animal model of Alzheimer’s Disease. Cell Stem Cell. 2015;17(4):397–411.

Article  PubMed  CAS  Google Scholar 

Calon F. Omega-3 polyunsaturated fatty acids in Alzheimer’s disease: key questions and partial answers. Curr Alzheimer Res. 2011;8(5):470–8.

Article  PubMed  CAS  Google Scholar 

Arsenault D, Julien C, Chen CT, Bazinet RP, Calon F. Dietary intake of unsaturated fatty acids modulates physiological properties of entorhinal cortex neurons in mice. J Neurochem. 2012;122(2):427–43.

Article  PubMed  CAS  Google Scholar 

Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, et al. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer’s disease. Neuroscience. 2009;159(1):296–307.

Article  PubMed  CAS  Google Scholar 

Kaplan RJ, Greenwood CE. Dietary saturated fatty acids and brain function. Neurochem Res. 1998;23(5):615–26.

Article  PubMed  CAS  Google Scholar 

Bazinet RP, Laye S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 2014;15(12):771–85.

Article  PubMed  CAS  Google Scholar 

Salem N, Vandal M, Calon F. The benefit of docosahexaenoic acid for the adult brain in aging and dementia. Prostaglandins Leukot Essent Fat Acids. 2015;92:15–22.

Article  CAS  Google Scholar 

Joffre C, Nadjar A, Lebbadi M, Calon F, Laye S. n-3 LCPUFA improves cognition: the young, the old and the sick. Prostaglandins Leukot Essent Fat Acids. 2014;91(1–2):1–20.

Article  CAS  Google Scholar 

Julien C, Berthiaume L, Hadj-Tahar A, Rajput AH, Bedard PJ, Di Paolo T, et al. Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys. Neurochem Int. 2006;48(5):404–14.

Article  PubMed  CAS  Google Scholar 

Bousquet M, Calon F, Cicchetti F. Impact of ω-3 fatty acids in Parkinson’s disease. Ageing Res Rev. 2011;10(4):453–63.

Article  PubMed  CAS  Google Scholar 

Hernando S, Requejo C, Herran E, Ruiz-Ortega JA, Morera-Herreras T, Lafuente JV, et al. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson’s disease: the role of glia and NRf2 regulation. Neurobiol Dis. 2019;121:252–62.

Article  PubMed  CAS  Google Scholar 

Bazan NG, Colangelo V, Lukiw WJ. Prostaglandins and other lipid mediators in Alzheimer’s disease. Prostaglandins Other Lipid Mediat. 2002;68–69:197–210.

Article  PubMed  Google Scholar 

Teismann P, Tieu K, Choi DK, Wu DC, Naini A, Hunot S, et al. Cyclooxygenase-2 is instrumental in Parkinson’s disease neurodegeneration. Proc Natl Acad Sci USA. 2003;100(9):5473–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kerdiles O, Layé S, Calon F. Omega-3 polyunsaturated fatty acids and brain health: preclinical evidence for the prevention of neurodegenerative diseases. Trends Food Sci Technol. 2017;69:203–13.

Article  CAS  Google Scholar 

Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse model. Neuron. 2004;43(5):633–45.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Arsenault D, Julien C, Tremblay C, Calon F. DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice. PLoS ONE. 2011;6(2):e17397.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Calon F, Lim GP, Morihara T, Yang F, Ubeda O, Salem N, et al. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer’s disease. Eur J Neurosci. 2005;22(3):617–26.

Article  PubMed  Google Scholar 

Casali BT, Corona AW, Mariani MM, Karlo JC, Ghosal K, Landreth GE. Omega-3 fatty acids augment the actions of Nuclear receptor agonists in a mouse model of Alzheimer’s Disease. J Neurosci. 2015;35(24):9173–81.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hooijmans CR, Van der Zee CE, Dederen PJ, Brouwer KM, Reijmer YD, van Groen T, et al. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol Dis. 2009;33(3):482–98.

Article  PubMed  CAS  Google Scholar 

Lim GP, Calon F, Morihara T, Yang F, Teter B, Ubeda O, et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci. 2005;25(12):3032–40.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Perez SE, Berg BM, Moore KA, He B, Counts SE, Fritz JJ, et al. DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects. J Neurosci Res. 2010;88(5):1026–40.

Article  PubMed  PubMed Central  CAS